SCHEMBL30168486

SCHEMBL30168486

CCCCCCCC=CC(=O)OCC(CO)OC(=O)C=CCCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 5/20 0.61
PRKCE Q02156 2/20 0.61
PRKCQ Q04759 2/20 0.61
PRKCD Q05655 2/20 0.61
FAAH O00519 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
HPGD P15428 1/20 0.48
CNR1 P21554 1/20 0.48
CNR2 P34972 1/20 0.48
S1PR1 P21453 1/20 0.47
DGKA P23743 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29577299 1.00 PRKCA (0.61) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL1285953 1.00 PRKCA (0.61) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL2701578 1.00 PRKCA (0.61) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL14718529 1.00 PRKCA (0.61) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL8389087 1.00 PRKCA (0.61) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL11221318 1.00 PRKCA (0.61) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL6565430 0.99 PRKCA (0.59) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL14957317 0.93 PRKCA (0.51) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL6324925 0.93 PRKCA (0.51) PRKCAPRKCEPRKCQPRKCDALDH1A1
SCHEMBL31326010 0.92 PRKCA (0.60) PRKCAPRKCEPRKCQPRKCDFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112188877-B Tympanostomy tube or subannular ventilation tube and other medical and fluid tube designs 哈佛学院院长及董事 2024-11-01 CN disclosed
CN-117222414-A Compounds for activating constant natural killer T-cells and methods for eliminating inflammatory senescent cells 脱落性治疗公司 2023-12-12 CN disclosed
CN-115666621-A Sustained release drug delivery systems with reduced impurities and related methods 度勒科特公司 2023-01-31 CN disclosed